Trastuzumab, CAS 180288-69-1

Description: Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.

CAS Number: 180288-69-1

Molecular Weight: 145.53 kDa

References: Zazo S, et al. Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines. Am J Cancer Res. 2016 Nov 1;6(11):2661-2678.

• Artikelnummer: TGMT9912-1mg
• Hersteller: TargetMol Chemicals
• Hersteller Artikelnummer: T9912-1mg
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK